These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 8869893)
1. Postchemotherapy connective tissue diseases--more than just rheumatism? Amft N; D'Cruz D Lupus; 1996 Aug; 5(4):255-6. PubMed ID: 8869893 [No Abstract] [Full Text] [Related]
2. [Rituximab. A monoclonal CD20 antibody--hematological indications and possible treatments for immunoinflammatory diseases]. Hansen PB; Hasselbalch HC Ugeskr Laeger; 2004 Feb; 166(6):466-9. PubMed ID: 15045710 [No Abstract] [Full Text] [Related]
3. The irreplaceable image: Nails changes in onco-hematologic patients. Vassallo C; Brazzelli V; Ardigò M; Borroni G Haematologica; 2001 Mar; 86(3):334-6. PubMed ID: 11255290 [No Abstract] [Full Text] [Related]
4. The gastrointestinal tract is a common target of invasive aspergillosis in patients receiving cytotoxic chemotherapy for hematological malignancy. Kami M; Hori A; Takaue Y; Mutou Y Clin Infect Dis; 2002 Jul; 35(1):105-6; author reply 106-7. PubMed ID: 12060886 [No Abstract] [Full Text] [Related]
5. [Traceability of oncohematological drugs through data capture codes]. Escudero-Vilaplana B; Manso-Manrique M; García-Sanz E; Sánchez-Guerrero A Farm Hosp; 2017 Sep; 41(5):649-650. PubMed ID: 28847260 [No Abstract] [Full Text] [Related]
6. [Fulminant hepatitis B as a result of reactivation in hematologic patient after chemotherapy combined with rituximab]. Cantudo-Muñoz P; Anguita-Arance MM; Muñoz-Peña C; Amores-Antequera C Rev Esp Quimioter; 2015 Feb; 28(1):56-7. PubMed ID: 25690147 [No Abstract] [Full Text] [Related]
14. [Thrombosis and DIC in hematological malignancies]. Asakura H Rinsho Ketsueki; 2014 Oct; 55(10):2066-75. PubMed ID: 25297773 [No Abstract] [Full Text] [Related]
15. Mucositis in the treatment of haematological malignancies. Niscola P; Scaramucci L; Romani C; Cupelli L; Tendas A; Dentamaro T; Ales M; Giovannini M; Piccioni D; Siniscalchi A; Tolu B; Perrotti A; Keefe D; de Fabritiis P Ann Oncol; 2008 Sep; 19 Suppl 7():vii141-5. PubMed ID: 18790936 [No Abstract] [Full Text] [Related]
16. Blood cancers, chemotherapy and the risks of neutropenia. Butters G Nurs Times; 2011 Mar 22-28; 107(11):19. PubMed ID: 21682165 [No Abstract] [Full Text] [Related]
17. Assessing the effects of treatments for hematological malignancies on prepubertal growth. Pearce MS Pediatr Hematol Oncol; 2000 Sep; 17(6):441-3. PubMed ID: 10989463 [No Abstract] [Full Text] [Related]
18. [Treatment of malignant hemopathies with all transretinoic acid]. Fenaux P; Chomienne C Presse Med; 1997 Oct; 26(29):1399-405. PubMed ID: 9404351 [No Abstract] [Full Text] [Related]
19. Onset of connective tissue disease following anti-PD1/PD-L1 cancer immunotherapy. Le Burel S; Champiat S; Routier E; Aspeslagh S; Albiges L; Szwebel TA; Michot JM; Chretien P; Mariette X; Voisin AL; Lambotte O Ann Rheum Dis; 2018 Mar; 77(3):468-470. PubMed ID: 28242618 [No Abstract] [Full Text] [Related]